GOSS
Price
$0.94
Change
-$0.04 (-4.08%)
Updated
Apr 3, 04:59 PM (EDT)
Capitalization
222.34M
40 days until earnings call
OCX
Price
$2.90
Change
-$0.06 (-2.03%)
Updated
Apr 3, 01:50 PM (EDT)
Capitalization
24.2M
Ad is loading...

GOSS vs OCX

Header iconGOSS vs OCX Comparison
Open Charts GOSS vs OCXBanner chart's image
Gossamer Bio
Price$0.94
Change-$0.04 (-4.08%)
Volume$18.16K
Capitalization222.34M
Oncocyte
Price$2.90
Change-$0.06 (-2.03%)
Volume$100
Capitalization24.2M
GOSS vs OCX Comparison Chart
Loading...
GOSS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OCX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GOSS vs. OCX commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GOSS is a Buy and OCX is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 03, 2025
Stock price -- (GOSS: $0.98 vs. OCX: $2.95)
Brand notoriety: GOSS and OCX are both not notable
GOSS represents the Biotechnology, while OCX is part of the Medical Specialties industry
Current volume relative to the 65-day Moving Average: GOSS: 105% vs. OCX: 68%
Market capitalization -- GOSS: $222.34M vs. OCX: $24.2M
GOSS [@Biotechnology] is valued at $222.34M. OCX’s [@Medical Specialties] market capitalization is $24.2M. The market cap for tickers in the [@Biotechnology] industry ranges from $308.32B to $0. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B. The average market capitalization across the [@Medical Specialties] industry is $8.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GOSS’s FA Score shows that 0 FA rating(s) are green whileOCX’s FA Score has 0 green FA rating(s).

  • GOSS’s FA Score: 0 green, 5 red.
  • OCX’s FA Score: 0 green, 5 red.
According to our system of comparison, OCX is a better buy in the long-term than GOSS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GOSS’s TA Score shows that 5 TA indicator(s) are bullish while OCX’s TA Score has 4 bullish TA indicator(s).

  • GOSS’s TA Score: 5 bullish, 4 bearish.
  • OCX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, GOSS is a better buy in the short-term than OCX.

Price Growth

GOSS (@Biotechnology) experienced а -17.08% price change this week, while OCX (@Medical Specialties) price change was -7.23% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.57%. For the same industry, the average monthly price growth was -10.69%, and the average quarterly price growth was -14.76%.

The average weekly price growth across all stocks in the @Medical Specialties industry was -4.10%. For the same industry, the average monthly price growth was +1.89%, and the average quarterly price growth was +1.69%.

Reported Earning Dates

GOSS is expected to report earnings on May 13, 2025.

OCX is expected to report earnings on Nov 09, 2023.

Industries' Descriptions

@Biotechnology (-8.57% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Medical Specialties (-4.10% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GOSS($222M) has a higher market cap than OCX($24.2M). OCX YTD gains are higher at: 23.950 vs. GOSS (8.169). OCX has higher annual earnings (EBITDA): -10.44M vs. GOSS (-39.97M). GOSS has more cash in the bank: 295M vs. OCX (14.2M). OCX has less debt than GOSS: OCX (3.07M) vs GOSS (203M). GOSS has higher revenues than OCX: GOSS (115M) vs OCX (1.46M).
GOSSOCXGOSS / OCX
Capitalization222M24.2M917%
EBITDA-39.97M-10.44M383%
Gain YTD8.16923.95034%
P/E RatioN/A4.56-
Revenue115M1.46M7,861%
Total Cash295M14.2M2,077%
Total Debt203M3.07M6,604%
FUNDAMENTALS RATINGS
GOSS vs OCX: Fundamental Ratings
GOSS
OCX
OUTLOOK RATING
1..100
6463
VALUATION
overvalued / fair valued / undervalued
1..100
65
Fair valued
56
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9999
PRICE GROWTH RATING
1..100
6243
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

OCX's Valuation (56) in the Medical Specialties industry is in the same range as GOSS (65) in the Pharmaceuticals Major industry. This means that OCX’s stock grew similarly to GOSS’s over the last 12 months.

OCX's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as GOSS (100) in the Pharmaceuticals Major industry. This means that OCX’s stock grew similarly to GOSS’s over the last 12 months.

OCX's SMR Rating (99) in the Medical Specialties industry is in the same range as GOSS (99) in the Pharmaceuticals Major industry. This means that OCX’s stock grew similarly to GOSS’s over the last 12 months.

OCX's Price Growth Rating (43) in the Medical Specialties industry is in the same range as GOSS (62) in the Pharmaceuticals Major industry. This means that OCX’s stock grew similarly to GOSS’s over the last 12 months.

OCX's P/E Growth Rating (100) in the Medical Specialties industry is in the same range as GOSS (100) in the Pharmaceuticals Major industry. This means that OCX’s stock grew similarly to GOSS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GOSSOCX
RSI
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
67%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
86%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 23 days ago
84%
Bullish Trend 8 days ago
79%
Declines
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
83%
Aroon
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
87%
View a ticker or compare two or three
Ad is loading...
GOSS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OCX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CPSH1.590.04
+2.58%
CPS Technologies Corp
XOMA19.780.48
+2.49%
XOMA Royalty Corporation
VRT77.111.84
+2.44%
Vertiv Holdings Co
BOX31.470.15
+0.48%
BOX
GB7.380.01
+0.14%
Global Blue Group Holding AG

OCX and

Correlation & Price change

A.I.dvisor indicates that over the last year, OCX has been loosely correlated with STRRP. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if OCX jumps, then STRRP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OCX
1D Price
Change %
OCX100%
-1.67%
STRRP - OCX
37%
Loosely correlated
N/A
FATE - OCX
31%
Poorly correlated
+1.70%
GOSS - OCX
29%
Poorly correlated
-1.59%
BMRN - OCX
29%
Poorly correlated
+0.56%
CRIS - OCX
28%
Poorly correlated
+1.37%
More